Expression of interleukin-15 in human skeletal muscle - effect of exercise and muscle fibre type composition

被引:188
作者
Nielsen, Anders Rinnov
Mounier, Remi
Plomgaard, Peter
Mortensen, Ole Hartvig
Penkowa, Milena
Speerschneider, Tobias
Pilegaard, Henriette
Pedersen, Bente Klarlund [1 ]
机构
[1] Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, Copenhagen, Denmark
[2] Rigshosp, Copenhagen Muscle Res Ctr, Copenhagen, Denmark
[3] Univ Copenhagen, Ctr Inflammat & Metab, Panum Inst, Sect Neuroprotect, Copenhagen, Denmark
[4] Univ Copenhagen, Ctr Inflammat & Metab, Dept Mol Biol, Copenhagen, Denmark
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2007年 / 584卷 / 01期
关键词
D O I
10.1113/jphysiol.2007.139618
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The cytokine interleukin-15 (IL-15) has been demonstrated to have anabolic effects in cell culture systems. We tested the hypothesis that IL-15 is predominantly expressed by type 2 skeletal muscle fibres, and that resistance exercise regulates IL-15 expression in muscle. Triceps brachii, vastus lateralis quadriceps and soleus muscle biopsies were obtained from normally physically active, healthy, young male volunteers (n = 14), because these muscles are characterized by having different fibre-type compositions. In addition, healthy, normally physically active male subjects (n = 8) not involved in any kind of resistance exercise underwent a heavy resistance exercise protocol that stimulated the vastus lateralis muscle and biopsies were obtained from this muscle pre-exercise as well as 6, 24 and 48 h post-exercise. IL-15 mRNA levels were twofold higher in the triceps (type 2 fibre dominance) compared with the soleus muscle (type 1 fibre dominance), but Western blotting and immunohistochemistry revealed that muscle IL-15 protein content did not differ between triceps brachii, quadriceps and soleus muscles. Following resistance exercise, IL-15 mRNA levels were up-regulated twofold at 24 h of recovery without any changes in muscle IL-15 protein content or plasma IL-15 at any of the investigated time points. In conclusion, IL-15 mRNA level is enhanced in skeletal muscles dominated by type 2 fibres and resistance exercise induces increased muscular IL-15 mRNA levels. IL-15 mRNA levels in skeletal muscle were not paralleled by similar changes in muscular IL-15 protein expression suggesting that muscle IL-15 may exist in a translationally inactive pool.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 30 条
[21]   Searching for the exercise factor: is IL-6 a candidate? [J].
Pedersen, BK ;
Steensberg, A ;
Fischer, C ;
Keller, C ;
Keller, P ;
Plomgaard, P ;
Febbraio, M ;
Saltin, B .
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2003, 24 (2-3) :113-119
[22]  
Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806
[23]  
Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53
[24]   Resistance exercise alters MRF and IGF-I mRNA content in human skeletal muscle [J].
Psilander, N ;
Damsgaard, R ;
Pilegaard, H .
JOURNAL OF APPLIED PHYSIOLOGY, 2003, 95 (03) :1038-1044
[25]   Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes:: Evidence for a skeletal muscle-to-fat signaling pathway [J].
Quinn, LBS ;
Strait-Bodey, L ;
Anderson, BG ;
Argilés, JM ;
Havel, PJ .
CELL BIOLOGY INTERNATIONAL, 2005, 29 (06) :449-457
[26]   INTERLEUKIN-15 - A NOVEL ANABOLIC CYTOKINE FOR SKELETAL-MUSCLE [J].
QUINN, LS ;
HAUGK, KL ;
GRABSTEIN, KH .
ENDOCRINOLOGY, 1995, 136 (08) :3669-3672
[27]   Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro:: Implications for treatment of muscle wasting disorders [J].
Quinn, LS ;
Anderson, BG ;
Drivdahl, RH ;
Alvarez, B ;
Argilés, JM .
EXPERIMENTAL CELL RESEARCH, 2002, 280 (01) :55-63
[28]   Interleukin-15 stimulates C2 skeletal myoblast differentiation [J].
Quinn, LS ;
Haugk, KL ;
Damon, SE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (01) :6-10
[29]   Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses [J].
Riechman, SE ;
Balasekaran, G ;
Roth, SM ;
Ferrell, RE .
JOURNAL OF APPLIED PHYSIOLOGY, 2004, 97 (06) :2214-2219
[30]  
Van Belle T, 2005, ARCH IMMUNOL THER EX, V53, P115